Protective effect of crocetin on hemorrhagic shock-induced acute renal failure in rats

Shock

Volumn 38, Issue 1, 2012, Pages 63-67

  Wang, Yunbo ^a   Yan, Junling ^b,c   Xi, Liang ^c,d   Qian, Zhiyu ^c   Wang, Zhenghong ^a   Yang, Lina ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Yunnan Baiyao Group Co Ltd   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Crocetin; cytokines; hemorrhagic shock; inflammatory mediators; renal failure

Indexed keywords

CREATINE; CROCETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG STRUCTURE; ENZYME ACTIVITY; HEMORRHAGIC SHOCK; KIDNEY DYSFUNCTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; RAT; RESUSCITATION; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; CAROTENOIDS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; INFLAMMATION MEDIATORS; KIDNEY; MALE; MALONDIALDEHYDE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SHOCK, HEMORRHAGIC; SUPEROXIDE DISMUTASE;

EID: 84862775023     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182596ec4     Document Type: Article

References (30)

1. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39(5):930-936, 2002. (Pubitemid 34454211)
2. Sahsivar MO, Narin C, Kiyici A, Toy H, Ege E, Sarigül A: The effect of iloprost on renal dysfunction after renal I/R using cystatin C and beta2-microglobulin monitoring. Shock 32(5):498-502, 2009.
3. Paller MS: The cell biology of reperfusion injury in the kidney. J Investig Med 42(4):632-639, 1994.
4. Eppihimer MJ, Granger DN: Ischemia/reperfusionYinduced leukocyteendothelial interactions in postcapillary venules. Shock 8(1):16-25, 1997. (Pubitemid 127709558)
5. Hierholzer C, Billiar TR: Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 386(4):302-308, 2001. (Pubitemid 32702760)
6. McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, Harwood S: Calpain inhibitor I reduces the activation of nuclear factor-kappa B and organ injury/dysfunction in hemorrhagic shock. FASEB J 15(1):171-186, 2001. (Pubitemid 32061668)
7. Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM: Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22(1):63-69, 2004. (Pubitemid 40228212)
8. Tseng TH, Chu CY, Huang JM, Shiow SJ, Wang CJ: Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett 97(1):61-67, 1995.
9. Yan J, Qian Z, Sheng L, Zhao B, Yang L, Ji H: Effect of crocetin on blood pressure restoration and synthesis of inflammatory mediators in heart after hemorrhagic shock in anesthetized rats. Shock 33(1):83-87, 2010.
10. Izumi M, McDonald MC, Sharpe MA, Chatterjee PK, Thiemermann C: Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock 18(3):230-235, 2002.
11. Wang CJ, Lee MJ, Chang MC, Lin JK: Inhibition of tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by crocetin. Carcinogenesis 16(2): 187-191, 1995.
12. Zheng S, Qian Z, Tang F, Sheng L: Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. Biochem Pharmacol 70(8):1192-1199, 2005. (Pubitemid 41317513)
13. Roy JW, Graham MC, Griffin AM, Gainer JL: A novel fluid resuscitation therapy for hemorrhagic shock. Shock 10(3):213-217, 1998. (Pubitemid 128464312)
14. Van Way CW 3rd, Dhar A, Morrison DC, Longorio MA, Maxfield DM: Cellular energetics in hemorrhagic shock: restoring adenosine triphosphate to the cells. J Trauma 54(Suppl 5):S169-S176, 2003. (Pubitemid 36758869)
15. Giassi LJ, Kennon PA, Gainer JL: Trans sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapy. Shock 18(6):585-588, 2002.
16. Singer M, Stidwill RP, Nathan A, Gainer JL: Intravenous crocetinate prolongs survival in a rat control of lethal hypoxemia. Crit Care Med 28(6):1968-1972, 2000. (Pubitemid 30428759)
17. Sheng L, Qian Z, Shi Y, Yang L, Xi L, Zhao B: Crocetin improves the insulin resistance induced by high-fat diet in rats. Br J Pharmacol 154(5):1016-1024, 2008. (Pubitemid 351915062)
18. Wang YH, Ge B, Yang XL, Zhai J, Yang LN, Wang XX: Proanthocyanidins from grape seeds modulates the nuclear factor-kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis. Int Immunopharmacol 11(10):1620-1627, 2011.
19. Zhang Y, Yao HP, Huang FF, Wu W, Gao Y, Chen ZB: Allicin, a major component of garlic, inhibits apoptosis in vital organs in rats with trauma/hemorrhagic shock. Crit Care Med 36(12):3226-3232, 2008.
20. Tsai MC, Chen WJ, Ching CH, Chuang JI: Resuscitation with hydroxyethyl starch solution prevents nuclear factor kappaB activation and oxidative stress after hemorrhagic shock and resuscitation in rats. Shock 27(5):527-533, 2007.
21. Eckardt KU, Bernhardt WM, Weidemann A, Warnecke C, Rosenberger C, Wiesener MS: Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl (99):S46-S51, 2005.
22. Efrati S, Berman S, Ben Aharon G, Siman-Tov Y, Averbukh Z, Weissgarten J: Application of normobaric hyperoxia therapy for amelioration of haemorrhagic shockYinduced acute renal failure. Nephrol Dial Transplant 23(7):2213-2222, 2008. (Pubitemid 351957614)
23. Mota-Filipe H, McDonald MC, Cuzzocrea S, Thiemermann C: A membranepermeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 12(4):255-261, 1999.
24. Yin M, Wheeler MD, Connor HD, Zhong Z, Bunzendahl H, Dikalova A: Cu/Zn-superoxide dismutase gene attenuates ischemia-reperfusion injury in the rat kidney. J Am Soc Nephrol 12(12):2691-2700, 2001. (Pubitemid 33115416)
25. Douzinas EE, Livaditi O, Andrianakis I, Prigouris P, Paneris P, Villiotou V: The effect of hypoxemic resuscitation from hemorrhagic shock on blood pressure restoration and on oxidative and inflammatory responses. Intensive Care Med 34(6):1133-1141, 2008. (Pubitemid 351903786)
26. Mauriz JL, Matilla B, Culebras JM, González P, González-Gallego J: Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat. Free Radic Biol Med 31(10):1236-1244, 2001. (Pubitemid 33052499)
27. Meng ZH, Dyer K, Billiar TR, Tweardy DJ: Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 280(2):C343-C351, 2001.
28. Szabo C, Billiar TR: Novel roles of nitric oxide in hemorrhagic shock. Shock 12(1):1-9, 1999.
29. Collins JL, Vodovotz Y, Hierholzer C, Villavicencio RT, Liu S, Alber S: Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock. Shock 19(2):117-122, 2003.
30. Szabó C, Módis K: Pathophysiological roles of peroxynitrite in circulatory shock. Shock 34(Suppl 1):4-14, 2010.